Featured Resources
-
STInG Webinar – Tackling dichotomania (p<0.05) and other statistical diseases in pursuit of better science
Ten years after the American Statistical Association released a statement recommending against the dichotomous interpretation of p-values, what has changed and what still needs to…
-
Applying the net benefit framework in trial-based cost-effectiveness analysis: a case study in arthroplasty prophylaxis
In this session, A/Prof Tran explains the principles of trial-based economic evaluation, the limitations of incremental cost-effectiveness ratios (ICERs), and the challenges of representing and…
-
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
Search Resources
General search and filters
Filter by:
Topics
Type of Resource
Results filtered by:
-
STInG Webinar – Tackling dichotomania (p<0.05) and other statistical diseases in pursuit of better science
-
Applying the net benefit framework in trial-based cost-effectiveness analysis: a case study in arthroplasty prophylaxis
-
Social value of a Childhood QALY- Revealed preferences from pharmaceutical funding decisions in Australia 2005–2023
-
ACTA STInG Webinar: The target trial framework for causal inference: a primer
-
Distributional cost-effectiveness analysis (DCEA) methods
-
ACTA 2024-2025 Annual Report
-
ACTA webinar – Estimating inequalities in health using quality-adjusted life expectancy: equity implications for health technology assessment and clinical trials
-
Teletrial insights: STOPNET (AGITG)
-
Teletrial insights: Socrates Trial (TROG)
-
Teletrial insights: MedCan 3 Trial (Mater Research)
-
Teletrials web resource
-
Teletrial insights: IMPEDE-PKD (AKTN)